Sign up to save your podcasts
Or
Share Considerations for Use of Two Newly Approved Drugs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Considerations for Use of Two Newly Approved Drugs
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
View all episodes
By Modern Optometry
5
1515 ratings
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
More shows like To the Point
View all
Power Hour Optometry
75 Listeners
The Doctor Youn Show
1,148 Listeners
The Dr. Hyman Show
9,194 Listeners
The Peter Attia Drive
8,043 Listeners
Blink Collective
63 Listeners
20/20 MONEY: The Business of Optometry
80 Listeners
The Everyday Style School
540 Listeners
The MOD Pod
5 Listeners
Four Eyes
18 Listeners
Optometry: The Ultimate O.D.
20 Listeners
Best Laid Plans
821 Listeners
Optometric Insights Media
21 Listeners
Dr. Streicher’s Inside Information: Menopause, Midlife, and More
376 Listeners
EYE OWN A BUSINESS
19 Listeners
Eye Give a Damn!
18 Listeners